WebSep 7, 2024 · Good Therapeutics Developing PD-1-regulated IL-2 Drugs Based on Innovative Conditionally Active Drug Technology SEATTLE, September 07, 2024 -- ( … WebSep 13, 2024 · Seattle-based biotech Good Therapeutics is being acquired by Swiss Pharmaceutical giant Roche for $250M, plus further payments for specified milestones. Once the acquisition is complete, Good Therapeutics will operate as Bonum Therapeutics, continuing to develop medicines for cancer and other diseases. The whole Good …
Our Company – Bonum Tx
WebSep 8, 2024 · Roche has signed a definitive merger agreement for the acquisition of US-based biopharmaceutical company Good Therapeutics for an upfront payment of … WebSep 7, 2024 · Sep. 7, 2024, 08:04 AM. (RTTNews) - Good Therapeutics Wednesday said Roche Holding AG (RHHBY) has agreed to acquire Good Therapeutics' conditionally active PD-1-regulated IL-2 Program. The deal ... koolatron cosmetic fridge
Roche to acquire biopharma firm Good Therapeutics for $250m
WebOur Team The entire team from Good Therapeutics has joined Bonum, bringing a tremendous track record of success and a passion for making a difference in the lives of patients. Management Team Board of Directors … Web2 days ago · Roche (OTCMKTS:RHHBY) already has a big investment there. And if SRPT’s gene therapy gets approved in the next few months, there’s probably a better than 50-50 chance that a company like Roche ... WebSep 7, 2024 · The deal gives Roche rights to Good Therapeutics' PD-1-regulated IL-2 drug currently in preclinical stage and exclusive rights to platform technology, with which it can advance other PD-1-regulated IL-2 receptor agonist drugs. Once the transaction closes, which is expected in the third quarter, all Good Therapeutics employees will move to a … koolatron customer service